House Resolution 841 aims to ensure that the Food and Drug Administration recognizes CBD products as dietary supplements. In Pharmacy Times, Ned Milenkovich, chair of Much’s Health Care group, shares how the bill may affect pharmacies, consumers, and the marketplace at large.